Guillain-Barré syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study

[1]  S. Salzberg,et al.  Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[2]  H. Willison,et al.  Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study , 2020, The Lancet Neurology.

[3]  J. Sejvar,et al.  Guillain-Barré syndrome in times of pandemics , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  B. Jacobs,et al.  Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype , 2020, PLoS neglected tropical diseases.

[5]  J. Sejvar,et al.  Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study , 2020, PloS one.

[6]  Ana Rodriguez,et al.  Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil , 2019, PLoS neglected tropical diseases.

[7]  P. Gallian,et al.  Chikungunya, a risk factor for Guillain-Barré syndrome. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  R. Césaire,et al.  Long-term outcome in neuroZika , 2019, Neurology.

[9]  S. Briolant,et al.  Variability of Zika Virus Incubation Period in Humans , 2018, Open forum infectious diseases.

[10]  G. Marfia,et al.  Regional variation of Guillain-Barré syndrome , 2018, Brain : a journal of neurology.

[11]  J. Sejvar,et al.  Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016 , 2018, JAMA neurology.

[12]  R. Lynch,et al.  Long-term clinical outcomes of Zika-associated Guillain-Barré syndrome , 2018, Emerging Microbes & Infections.

[13]  J. Anaya,et al.  Clinical and nerve conduction features in Guillain−Barré syndrome associated with Zika virus infection in Cúcuta, Colombia , 2018, European journal of neurology.

[14]  A. Tanuri,et al.  Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection , 2018, Front. Med..

[15]  T. Solomon,et al.  The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series , 2018, PLoS neglected tropical diseases.

[16]  L. Pena,et al.  Guillain-Barré Syndrome, Acute Disseminated Encephalomyelitis and Encephalitis Associated with Zika Virus Infection in Brazil: Detection of Viral RNA and Isolation of Virus during Late Infection. , 2017, The American journal of tropical medicine and hygiene.

[17]  Thomas Jaenisch,et al.  Zika virus displacement by a chikungunya outbreak in Recife, Brazil , 2017, PLoS neglected tropical diseases.

[18]  J. Muñoz-Jordán,et al.  Acute Zika Virus Infection as a Risk Factor for Guillain-Barré Syndrome in Puerto Rico , 2017, JAMA.

[19]  R. Césaire,et al.  Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Cordeiro,et al.  Central and peripheral nervous system involvement caused by Zika and chikungunya coinfection , 2017, PLoS neglected tropical diseases.

[21]  C. Dye,et al.  Zika Virus Infection and Associated Neurologic Disorders in Brazil. , 2017, The New England journal of medicine.

[22]  Y. Fragoso,et al.  Guillain-Barré syndrome and dengue fever: report on ten new cases in Brazil , 2016, Arquivos de Neuro-Psiquiatria.

[23]  J. Muñoz-Jordán,et al.  Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November 1, 2015-October 20, 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[24]  Jairo Lizarazo,et al.  Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia. , 2016, The New England journal of medicine.

[25]  Daniel A M Villela,et al.  Higher incidence of Zika in adult women than adult men in Rio de Janeiro suggests a significant contribution of sexual transmission from men to women. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  H. Endtz,et al.  Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[27]  A. Chiba,et al.  Ca2+-dependent anti-GQ1b antibody in GQ1b-seronegative Fisher syndrome and related disorders , 2016, Journal of Neuroimmunology.

[28]  H. Willison,et al.  Asymptomatic dengue infection may trigger Guillain‐Barré syndrome , 2016, Journal of the peripheral nervous system : JPNS.

[29]  C. Brito,et al.  Zika in Pernambuco: rewriting the first outbreak. , 2016, Revista da Sociedade Brasileira de Medicina Tropical.

[30]  Emmanuel Fournier,et al.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study , 2016, The Lancet.

[31]  N. Molko,et al.  Early Guillain-Barré Syndrome associated with acute dengue fever. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[32]  Scott C Weaver,et al.  Chikungunya virus and the global spread of a mosquito-borne disease. , 2015, The New England journal of medicine.

[33]  N. Yuki,et al.  Guillain–Barré and Miller Fisher syndromes—new diagnostic classification , 2014, Nature Reviews Neurology.

[34]  Kara E. Rudolph,et al.  Incubation periods of mosquito-borne viral infections: a systematic review. , 2014, The American journal of tropical medicine and hygiene.

[35]  J. Farrar,et al.  Neurological complications of dengue virus infection , 2013, The Lancet Neurology.

[36]  H. Margolis,et al.  Correction: Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus , 2013, PLoS Neglected Tropical Diseases.

[37]  H. Margolis,et al.  Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus , 2013, PLoS neglected tropical diseases.

[38]  D. Orlikowski,et al.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain–Barré syndrome patients , 2011, Journal of Neurology.

[39]  R. Porcher,et al.  Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Blok,et al.  Guillain–Barré syndrome subtypes related to Campylobacter infection , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  J. Sejvar,et al.  Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. , 2011, Vaccine.

[42]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[43]  M. G. Ciufolini,et al.  Chikungunya in north-eastern Italy: a summing up of the outbreak. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[44]  H. Schatzmayr,et al.  Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. , 2007, Revista da Sociedade Brasileira de Medicina Tropical.

[45]  R. Lanciotti,et al.  Chikungunya Virus in US Travelers Returning from India, 2006 , 2007, Emerging infectious diseases.

[46]  N. Yuki,et al.  Epidemiology of Campylobacter jejuni Isolated from Patients with Guillain-Barré and Fisher Syndromes in Japan , 2005, Journal of Clinical Microbiology.

[47]  K. Hirata,et al.  Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  L. R. Petersen,et al.  Zika Virus. , 2016, The New England journal of medicine.

[49]  N. Yuki,et al.  Guillain–Barré and Miller Fisher syndromes—new diagnostic classification , 2014, Nature Reviews Neurology.

[50]  A. Saporito,et al.  Declaration of interest , 2010 .